Shares of Cardio Diagnostics Holdings, Inc. (CDIO), an artificial intelligence-powered precision cardiovascular medicine company, are rising nearly 150% Tuesday morning following the launch of PrecisionCHD, a blood test for the early detection of coronary heart disease.
PrecisionCHD, a non-invasive test detects coronary heart disease with better than 75% sensitivity in both men and women. the company said.
CDIO is at $3.15 currently. It has traded in the range of $0.79-$10.25 in the last 1 year.
Source: Read Full Article
Lates News:
-
Data Highlights Massive BTC Accumulation By Whales As 'Extreme Fear' Grips Bitcoin Price
-
Markets Nervous As Debt Limit Deadlock Persists
-
If Bitcoin Is So Valuable, Why Is It Down So Much This Year?
-
Michael Saylor Calls Bitcoin The ‘The Apex Commodity,’ Predicts Long-Term Outperformance Over Cash, Stocks, S&P 500
-
Cathie Wood: SEC Staff Understand Bitcoin and Its Merits